Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
暂无分享,去创建一个
Ricardo Azziz | Mark O. Goodarzi | M. Goodarzi | R. Azziz | D. Dumesic | Daniel A. Dumesic | Gregorio Chazenbalk | G. Chazenbalk
[1] J. Dungan. Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis , 2008 .
[2] M. Hull. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. , 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[3] F. Manguso,et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. , 2007, Human reproduction.
[4] E. Diamanti-Kandarakis,et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). , 2001, American journal of physiology. Endocrinology and metabolism.
[5] O. Ortmann,et al. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. , 1999, Human reproduction.
[6] M. Davies,et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. , 2001, Human reproduction.
[7] J. Goldberg,et al. Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study. , 2006, Journal of affective disorders.
[8] G. Conway,et al. Polycystic ovary syndrome : a guide to clinical management , 2005 .
[9] S. Whitehead,et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. , 2007, The Journal of clinical endocrinology and metabolism.
[10] G. Azevedo,et al. [Menstrual cycle irregularity as a marker of cardiovascular risk factors at postmenopausal years]. , 2006, Arquivos brasileiros de endocrinologia e metabologia.
[11] M. Byrne,et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.
[12] Ana M Soto,et al. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. , 2009, Endocrine reviews.
[13] R. Azziz,et al. Androgen excess disorders in women , 2007 .
[14] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[15] W. Wiser,et al. Hyperthecosis: an inheritable form of polycystic ovarian disease. , 1975, Birth defects original article series.
[16] M. Hickey,et al. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. , 2009, The Journal of clinical endocrinology and metabolism.
[17] E. Diamanti-Kandarakis,et al. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. , 2010, European journal of endocrinology.
[18] T. Lesnick,et al. Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. , 2004, The Journal of clinical endocrinology and metabolism.
[19] T. Lesnick,et al. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. , 2006, The Journal of clinical endocrinology and metabolism.
[20] E. Carmina,et al. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. , 2009, European journal of endocrinology.
[21] S. Bhattacharya,et al. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. , 2009, Reproductive biomedicine online.
[22] K. Højlund,et al. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. , 2008, The Journal of clinical endocrinology and metabolism.
[23] R. Azziz. The evaluation and management of hirsutism. , 2003, Obstetrics and gynecology.
[24] A. López-Bermejo,et al. Low body adiposity and high leptinemia in breast-fed infants born small-for-gestational-age. , 2010, The Journal of pediatrics.
[25] E. Talbott,et al. Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up , 2006, Current diabetes reports.
[26] H. Mason,et al. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. , 1994, The Journal of clinical endocrinology and metabolism.
[27] J. Marshall,et al. Regulation of Gonadotropin Secretion: Implications for Polycystic Ovary Syndrome , 2002, Seminars in reproductive medicine.
[28] I. Stein,et al. Amenorrhea associated with bilateral polycystic ovaries , 1935 .
[29] P. Lavori,et al. Valproate Is Associated with New-Onset Oligoamenorrhea with Hyperandrogenism in Women with Bipolar Disorder , 2006, Biological Psychiatry.
[30] M. McCarthy,et al. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. , 2004, The Journal of clinical endocrinology and metabolism.
[31] M. Goodarzi,et al. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. , 2009, The Journal of clinical endocrinology and metabolism.
[32] R. Steegers-Theunissen,et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. , 2008, The Journal of clinical endocrinology and metabolism.
[33] R. Lobo,et al. Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation. , 1995, Human reproduction.
[34] K. Segal,et al. Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.
[35] S. Emans,et al. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.
[36] A Sekikawa,et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.
[37] P. Magnus,et al. Familial clustering in the polycystic ovarian syndrome. , 1989, Gynecologic and obstetric investigation.
[38] R. Casper,et al. Review: aromatase inhibitors for ovulation induction. , 2006, The Journal of clinical endocrinology and metabolism.
[39] John A. Barry,et al. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels , 2010, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[40] E. Codner,et al. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[41] A. González-Bulnes. Novel concepts in ovarian endocrinology. , 2007 .
[42] R. Norman,et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. , 2006, The Journal of clinical endocrinology and metabolism.
[43] S. Nussey,et al. Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries , 2004, Clinical endocrinology.
[44] M. Eijkemans,et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. , 2006, Human reproduction update.
[45] W. Crowley,et al. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. , 1988, The Journal of clinical endocrinology and metabolism.
[46] Thessaloniki,et al. Consensus on infertility treatment related to polycystic ovary syndrome. , 2008, Fertility and sterility.
[47] L. Liao,et al. Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells , 2008, Molecular and Cellular Endocrinology.
[48] J. Supko,et al. Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[49] S. Elsenbruch,et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome , 2008, Brain, Behavior, and Immunity.
[50] F. de Zegher,et al. Early Origins of polycystic ovary syndrome: hypotheses may change without notice. , 2009, The Journal of clinical endocrinology and metabolism.
[51] A. Lucky,et al. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome , 1990 .
[52] R. Azziz,et al. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. , 1998, Fertility and sterility.
[53] E. Wickham,et al. Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. , 2007, The Journal of clinical endocrinology and metabolism.
[54] L. Moran,et al. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. , 2009, Human reproduction update.
[55] Lee-wen Huang,et al. IVF versus ICSI in sibling oocytes from patients with polycystic ovarian syndrome: a randomized controlled trial. , 2005, Human reproduction.
[56] J. Nestler,et al. 0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(4):1929–1935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1045 Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycysti , 2022 .
[57] A. Dokras,et al. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. , 2009, Fertility and sterility.
[58] A. Vidal-Puig,et al. It's Not How Fat You Are, It's What You Do with It That Counts , 2008, PLoS biology.
[59] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[60] F. Schmidt. Meta-Analysis , 2008 .
[61] M. Cavaghan,et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.
[62] T. Arora,et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. , 2000, The Journal of clinical endocrinology and metabolism.
[63] Y. Taketani,et al. Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats. , 2004, Biochemical and biophysical research communications.
[64] Judith R. Rager,et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[65] R. Norman,et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. , 2010, The Journal of clinical endocrinology and metabolism.
[66] R. Cífková,et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. , 2000, Human reproduction.
[67] S. Reis,et al. The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation , 2006, Circulation.
[68] R. Azziz,et al. Visually scoring hirsutism. , 2010, Human reproduction update.
[69] W. Dodson,et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.
[70] S. Mudaliar,et al. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. , 2009, The Journal of clinical endocrinology and metabolism.
[71] S. Reis,et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. , 2008, The Journal of clinical endocrinology and metabolism.
[72] S. Reeders,et al. FAMILIAL POLYCYSTIC OVARIES: A GENETIC DISEASE? , 1988, Clinical endocrinology.
[73] H. Mason,et al. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. , 1996, The Journal of clinical endocrinology and metabolism.
[74] M. Goodarzi,et al. Polycystic ovary syndrome: an ancient disorder? , 2011, Fertility and sterility.
[75] S. Necozione,et al. Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome. , 2008, Metabolism: clinical and experimental.
[76] G. Rini,et al. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. , 2009, Fertility and sterility.
[77] P. G. Knight,et al. Local roles of TGF-beta superfamily members in the control of ovarian follicle development. , 2003, Animal reproduction science.
[78] M. Goodarzi,et al. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.
[79] anonymous,et al. Comprehensive review , 2019 .
[80] R. Azziz,et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. , 2001, Fertility and sterility.
[81] K. Taylor,et al. Androgen excess in women: experience with over 1000 consecutive patients. , 2004, The Journal of clinical endocrinology and metabolism.
[82] J. Suls,et al. Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.
[83] E. Codner,et al. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[84] M. McCarthy,et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms , 2003, International Journal of Obesity.
[85] Y. Taketani,et al. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. , 2004, Endocrine journal.
[86] R. Wild. Long-term health consequences of PCOS. , 2002, Human reproduction update.
[87] R. Azziz,et al. Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. , 2010, The Journal of clinical endocrinology and metabolism.
[88] J. Marshall,et al. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. , 2006, Human reproduction update.
[89] B. Bavister,et al. A macaque model for studying mechanisms controlling oocyte development and maturation in human and non-human primates. , 1999, Human reproduction.
[90] D. Dewailly,et al. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? , 2003, Human reproduction.
[91] Ravinder J. Singh,et al. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. , 2010, The Journal of clinical endocrinology and metabolism.
[92] M. Sauer,et al. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. , 2000, The Journal of clinical endocrinology and metabolism.
[93] V. Preedy,et al. Prospective Cohort Study , 2010 .
[94] B. Urman,et al. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. , 1992, Fertility and sterility.
[95] A. Gadducci,et al. Polycystic ovary syndrome and gynecological cancers: Is there a link? , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[96] V. Padmanabhan,et al. Polycystic ovary syndrome and its developmental origins , 2007, Reviews in Endocrine and Metabolic Disorders.
[97] R. Casper,et al. Aromatase Inhibitors for Ovulation Induction , 2006 .
[98] L. Kuller,et al. Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[99] B. Grubb,et al. Clinical signs of androgen excess as risk factors for coronary artery disease. , 1990, Fertility and sterility.
[100] J. Wood,et al. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. , 2007, The Journal of clinical endocrinology and metabolism.
[101] M. Primeau,et al. Androgens and Mood Dysfunction in Women: Comparison of Women With Polycystic Ovarian Syndrome to Healthy Controls , 2004, Psychosomatic medicine.
[102] J. L. San Millán,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .
[103] M. Eijkemans,et al. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors , 2006, BJOG : an international journal of obstetrics and gynaecology.
[104] L. Moran,et al. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. , 2009, Fertility and sterility.
[105] Rita Ouellet-Hellstrom,et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. , 2010, JAMA.
[106] R. Pasquali,et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. , 1989, The Journal of clinical endocrinology and metabolism.
[107] E. Codner,et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. , 2005, Human reproduction.
[108] G. Guyatt,et al. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. , 2004, Journal of clinical epidemiology.
[109] Janet E Hall,et al. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. , 2006, The Journal of clinical endocrinology and metabolism.
[110] M. Rizzo,et al. Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? , 2005, Journal of atherosclerosis and thrombosis.
[111] R. Norman,et al. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. , 1999, The Journal of clinical endocrinology and metabolism.
[112] R. Azziz,et al. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. , 2009, The Journal of clinical endocrinology and metabolism.
[113] A. Corbould. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? , 2008, Panminerva medica.
[114] V. Hiilesmaa,et al. Obstetric outcome in women with polycystic ovarian syndrome. , 2001, Human reproduction.
[115] R. Norman,et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. , 2009, Fertility and sterility.
[116] T. Suppes,et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. , 2005, Bipolar disorders.
[117] C. Berne,et al. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. , 1994, The Journal of clinical endocrinology and metabolism.
[118] M. McCarthy,et al. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. , 2005, The Journal of clinical endocrinology and metabolism.
[119] H. Bettiol,et al. High prevalence of polycystic ovary syndrome in women born small for gestational age. , 2010, Human reproduction.
[120] S. Weitsman,et al. 5α-Reductase Activity in Women with Polycystic Ovary Syndrome1 , 1999 .
[121] Ricardo Azziz,et al. 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .
[122] M. Urbanek,et al. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. , 2005, The Journal of clinical endocrinology and metabolism.
[123] V. Padmanabhan,et al. Polycystic Ovary Syndrome and Oocyte Developmental Competence , 2008, Obstetrical & gynecological survey.
[124] M. Hersberger,et al. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. , 2009, Human reproduction.
[125] P. Hardiman,et al. Polycystic Ovary Syndrome and Endometrial Cancer , 2008, Seminars in reproductive medicine.
[126] R. Legro,et al. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. , 2009, The Journal of clinical endocrinology and metabolism.
[127] E. Carmina,et al. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome , 2008, Journal of endocrinological investigation.
[128] J. Marshall,et al. Neuroendocrine aspects of polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.
[129] G. Rini,et al. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. , 2005, The Journal of clinical endocrinology and metabolism.
[130] E. Diamanti-Kandarakis,et al. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[131] M. Maliqueo,et al. Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome. , 2009, Fertility and sterility.
[132] 角田 明良,et al. 結腸癌術後の早期離床・早期経口摂取に関するProspective Randomized Trial , 2002 .
[133] D. Abbott,et al. Early origins of polycystic ovary syndrome. , 2005, Reproduction, fertility, and development.
[134] D. Driscoll,et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[135] H. Raff,et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. , 2007, The Journal of clinical endocrinology and metabolism.
[136] M. Frye,et al. Longitudinal evaluation of reproductive function in women treated for bipolar disorder. , 2005, Journal of affective disorders.
[137] Polycystic ovaries and associated clinical and biochemical features in young women , 1999, Clinical endocrinology.
[138] J. Marshall,et al. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. , 2005, The Journal of clinical endocrinology and metabolism.
[139] R. Norman,et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. , 2010, Human reproduction.
[140] A. Kunselman,et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. , 2005, The Journal of clinical endocrinology and metabolism.
[141] R. Azziz,et al. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. , 1999, Fertility and sterility.
[142] A. Lucky,et al. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. , 1990, Fertility and sterility.
[143] F. Orio,et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. , 2006, The American journal of medicine.
[144] A. Kunselman,et al. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. , 2001, The American journal of medicine.
[145] J. Visser,et al. Anti-Müllerian hormone: a new marker for ovarian function. , 2006, Reproduction.
[146] S. Killick,et al. Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility. , 2003, Fertility and sterility.
[147] T. Key,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .
[148] A. Marolt. [Facts and hypotheses]. , 1953, Schweizerische Monatsschrift fur Zahnheilkunde = Revue mensuelle suisse d'odonto-stomatologie.
[149] D. Abbott,et al. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? , 2005, Human reproduction update.
[150] D. Ehrmann,et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[151] F. Orio,et al. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. , 2009, Endocrine reviews.
[152] S. Weitsman,et al. Aromatase mRNA expression in individual follicles from polycystic ovaries. , 1998, Molecular human reproduction.
[153] V. Padmanabhan,et al. Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female , 2006, Molecular and Cellular Endocrinology.
[154] D. Seifer,et al. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. , 2007, Fertility and sterility.
[155] R. Azziz,et al. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. , 2005, Fertility and sterility.
[156] H. S. Davis,et al. A Controlled Study , 1966 .
[157] B. Carlsson,et al. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. , 1993, Fertility and sterility.
[158] W. Crowley,et al. Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome , 1998, Journal of endocrinological investigation.
[159] K. Højlund,et al. Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment , 2008, Diabetes.
[160] A. Vidal-Puig,et al. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. , 2010, Biochimica et biophysica acta.
[161] K. Sengoku,et al. The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. , 1997, Human reproduction.
[162] M. Hongo,et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. , 2000, Metabolism: clinical and experimental.
[163] A. Gougeon. Regulation of ovarian follicular development in primates: facts and hypotheses. , 1996, Endocrine reviews.
[164] A. Balen,et al. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? , 2002, Clinical endocrinology.
[165] A. Kunselman,et al. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.
[166] A. Badawy,et al. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. , 2009, Fertility and sterility.
[167] R. Azziz,et al. Impact of obesity on the risk for polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.
[168] M. Goodarzi. Looking for polycystic ovary syndrome genes: rational and best strategy. , 2008, Seminars in reproductive medicine.
[169] Mark I McCarthy,et al. Mechanisms of Disease: genetic insights into the etiology of type 2 diabetes and obesity , 2008, Nature Clinical Practice Endocrinology &Metabolism.
[170] G. Di Fede,et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. , 2007, The Journal of clinical endocrinology and metabolism.
[171] J. Adams,et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. , 2006, The Journal of clinical endocrinology and metabolism.
[172] Family-based analysis of candidate genes for polycystic ovary syndrome. , 2010, The Journal of clinical endocrinology and metabolism.
[173] C. Simón,et al. Oocyte quality in polycystic ovaries revisited: Identification of a particular subgroup of women , 1997, Journal of Assisted Reproduction and Genetics.
[174] Técia Maria do Oliveira Maranhão,et al. Irregularidade do ciclo menstrual no menacme como marcador para fatores de risco cardiovasculares na pós-menopausa , 2006 .
[175] E. Diamanti-Kandarakis,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.
[176] D. Boomsma,et al. 0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(6):2100–2104 Printed in U.S.A. Copyright © 2006 by The Endocrine Society doi: 10.1210/jc.2005-1494 Heritability of Polycystic Ovary Syndrome in a Dutch Twin-Family Study , 2022 .
[177] M. Muggeo,et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. , 2000, The Journal of clinical endocrinology and metabolism.
[178] F. de Zegher,et al. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. , 1998, The Journal of clinical endocrinology and metabolism.
[179] S. Bhasin,et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. , 2009, The Journal of clinical endocrinology and metabolism.
[180] S. Agarwal,et al. A mechanism for the suppression of estrogen production in polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[181] L. Levitsky,et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. , 1994, The Journal of clinical endocrinology and metabolism.
[182] S. Caprio,et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. , 2007, The Journal of clinical endocrinology and metabolism.
[183] E. Diamanti-Kandarakis,et al. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. , 2001, The Journal of clinical endocrinology and metabolism.
[184] D. Ferriman,et al. THE INHERITANCE OF POLYCYSTIC OVARIAN DISEASE AND A POSSIBLE RELATIONSHIP TO PREMATURE BALDING , 1979, Clinical endocrinology.
[185] Ximena Duque,et al. Prevalence of Polycystic Ovary Syndrome and Related Disorders in Mexican Women , 2010, Gynecologic and Obstetric Investigation.
[186] K. Chad,et al. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. , 2006, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[187] Maja O’Connor. LONGITUDINAL STUDY , 2013 .
[188] F. Booth,et al. Eating, exercise, and "thrifty" genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. , 2004, Journal of applied physiology.
[189] D. Ehrmann,et al. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.
[190] V. Myllylä,et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. , 1994, The New England journal of medicine.
[191] D. Dewailly,et al. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. , 2006, The Journal of clinical endocrinology and metabolism.
[192] D. Panidis,et al. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS. , 2006, European journal of endocrinology.
[193] R. Azziz,et al. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. , 2010, Fertility and sterility.
[194] L. Kuller,et al. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. , 1996, American journal of obstetrics and gynecology.
[195] J. Olefsky,et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. , 1992, The Journal of clinical endocrinology and metabolism.
[196] D. Rosenbaum,et al. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. , 1993, The American journal of physiology.
[197] F. Greenway,et al. An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: , 2010 .
[198] J. Ruderman. Faculty Opinions recommendation of The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. , 2006 .
[199] R. Wing,et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. , 1994, Fertility and sterility.
[200] S. Franks,et al. Insulin action in the normal and polycystic ovary. , 1999, Endocrinology and metabolism clinics of North America.
[201] D. Schoenfeld,et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.
[202] R. Hart,et al. Circulating maternal testosterone concentrations at 18 weeks of gestation predict circulating levels of antimüllerian hormone in adolescence: a prospective cohort study. , 2010, Fertility and sterility.
[203] L. Moran,et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. , 2010, Human reproduction update.
[204] V. Meyer-Rochow,et al. Insulin Resistance and Depressive Symptoms in Young Adult Males: Findings From Finnish Military Conscripts , 2007, Psychosomatic medicine.
[205] V. Padmanabhan,et al. Endocrine Antecedents of Polycystic Ovary Syndrome in Fetal and Infant Prenatally Androgenized Female Rhesus Monkeys1 , 2008, Biology of reproduction.
[206] M. Eijkemans,et al. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. , 2006, Human reproduction update.
[207] R. Lobo,et al. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. , 2004, Fertility and sterility.
[208] J. Nestler. Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective. , 2008, Fertility and sterility.
[209] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[210] B. V. Van Voorhis,et al. Increased risk of depressive disorders in women with polycystic ovary syndrome. , 2007, Fertility and sterility.
[211] T. Ciaraldi,et al. Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.
[212] T. Gurgan,et al. Pregnancy in infertile PCOD patients. Complications and outcome. , 1997, The Journal of reproductive medicine.
[213] H. Picton,et al. South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts. , 2007, European journal of obstetrics, gynecology, and reproductive biology.
[214] M. Burns,et al. Case-Control Study , 2020, Definitions.
[215] H. Escobar-Morreale,et al. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. , 2007, Human reproduction.
[216] S. Weerakiet,et al. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[217] F. V. van Leeuwen,et al. Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort. , 2003, Human reproduction.
[218] R. Legro,et al. Bone mineral density and body composition in lean women with polycystic ovary syndrome. , 1999, Fertility and sterility.
[219] S. Franks,et al. Fertilization and early embryology: Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries , 1995 .
[220] S L Wolf,et al. An Alternative Perspective , 1999, Applied psychophysiology and biofeedback.
[221] E. Barrett-Connor,et al. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease , 2007, Menopause.
[222] R. Legro,et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. , 2003, Human reproduction.
[223] D. Abbott,et al. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys , 2009, American journal of primatology.
[224] J. Olefsky,et al. Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. , 1997, The Journal of clinical endocrinology and metabolism.
[225] R. Clayton,et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? , 1992, Clinical endocrinology.
[226] A. Dokras,et al. Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome , 2005, Obstetrics and gynecology.
[227] L. Altshuler,et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. , 2003, Journal of affective disorders.
[228] W. Dodson,et al. Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. , 2010, The Journal of clinical endocrinology and metabolism.
[229] R. Rosenfield. Clinical review: Identifying children at risk for polycystic ovary syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[230] A. Oberg,et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[231] L. Giudice,et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.
[232] R. Norman,et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. , 1998, Human reproduction.
[233] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[234] A. Prentice,et al. Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: A fertility first hypothesis , 2009, American journal of human biology : the official journal of the Human Biology Council.
[235] N. Cox,et al. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. , 2001, The Journal of clinical endocrinology and metabolism.
[236] M. Maliqueo,et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. , 2002, Human reproduction.
[237] R. Norman,et al. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. , 2007, The Journal of clinical endocrinology and metabolism.
[238] Paloma Alonso-Magdalena,et al. The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance , 2005, Environmental health perspectives.
[239] H. White,et al. Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization , 1997, Annals of Internal Medicine.